Hematological parameters influencing the Thrombostat 4000

Area of Science:

• Hematology
• Clinical Pathology

Background:

• In-vitro bleeding time (IVBT) is a crucial parameter for assessing hemostasis.
• Understanding the influence of key blood components on IVBT is essential for accurate diagnostic interpretation.

Purpose of the Study:

• To investigate the effects of platelet counts, hematocrit, and leukocyte counts on the closure times measured by the Thrombostat 4000 device.
• To establish correlations between these blood parameters and in-vitro bleeding time.

Main Methods:

• Utilized the Thrombostat 4000 device to measure in-vitro bleeding time (IVBT).
• Analyzed variations in closure times across different levels of platelet counts, hematocrit, and leukocyte counts.
• Included leukocytes from a patient with chronic myelocytic leukemia for comparative analysis.

Main Results:

• Prolonged closure times were observed with platelet counts below 50 x 10(9)/L, showing an inverse linear correlation.
• Hematocrit demonstrated an inverse correlation with closure time; high hematocrit (55%) resulted in immediate closure, while low hematocrit (<15%) prevented closure.
• Increased counts of both mononuclear and polymorphonuclear leukocytes led to shorter closure times, an effect also noted with leukocytes from a chronic myelocytic leukemia patient.

Conclusions:

• Platelet count, hematocrit, and leukocyte count are significant determinants of in-vitro bleeding time.
• These findings highlight the importance of considering these hematological parameters when interpreting IVBT results.
• Leukocyte influence on IVBT may extend to pathological conditions like chronic myelocytic leukemia.